Atrial Fibrillation: Technologies and Global Markets

Report Code: HLC198A

Publish Date: Nov 2018

Publisher: BCC Publishing

Category: Health Maintenance

Customize This Report

Single User License: $2500

Member Price: FREE

Explore Our Services

Already a member? Login to access this report free.

Report Highlights

The global market for atrial fibrillation devices should grow from $4.1 billion in 2018 to $7.8 billion by 2023 at a compound annual growth rate (CAGR) of 13.6% for the period of 2018-2023.

Report Includes

  • 25 data tables and 13 additional tables
  • An overview of the global market for atrial fibrillation and technologies
  • Analyses of global market trends, with data from 2017, estimates for 2018, and projections of compound annual growth rates (CAGRs) through 2023
  • Detailed description of the market for drug treatment, surgical intervention, and other aspects of atrial fibrillation
  • Discussion of the types of atrial fibrillation treatment
  • A look into various government regulations
  • Insight into the emerging developmental technologies and clinical trials for new technology for atrial fibrillation
  • Company profiles of the manufacturers of surgical equipment, surgical accessories, and pharmaceuticals, including Abbott Laboratories, Aegis Medical Innovations, Boston Scientific, GE Healthcare, Johnson & Johnson, Medtronic and Philips Healthcare

Report Scope

The report on Atrial Fibrillation: Technologies and Global Markets covers interventional procedural products, namely Cardiac Ablation products and Left Atrial Appendage closure devices.

Devices included as a part of market estimates are:

  • Catheter ablation products, including electrophysiology ablation catheters, electrophysiology diagnostic catheters, lab systems (3D electro-anatomical mapping systems, robotic catheter navigation systems, intracardiac echocardiography systems, recording systems, ablation generators and irrigation pumps), access devices and consumables.
  • Left atrial appendage closure devices, including all occlusion device systems and implantable devices employed in endocardial and epicardial LAA procedures, which include cardiac plugs, clips and suture delivery systems.

Devices excluded from market estimates are:

  • Pharmacological drugs employed in standalone and combination of ablation procedures.
  • Devices like defibrillators and preliminary diagnostic devices, including cardiac monitors and Holter monitors (including implantable Holter monitors).
  • ECG machines and consumables, wearable devices, implantable loop recorders (ILR), pacemakers, and electrical cardioversion devices.
  • Further surgical ablation products employed in Cox-Maze IV or Mini-Maze surgery and thoracoscopy visualization devices.
  • Imaging systems such as Rotational angiography, fluoroscopy X-ray systems, CT and MRI imaging systems.

The report covers the market dynamics and trends that are shaping the atrial fibrillation treatment interventions. Other subjects discussed in the report are key qualitative factors like epidemiology, categories of atrial fibrillation, key device development and regulations.

The market landscape of atrial fibrillation was studied at a regional level covering North America, Europe, Asia-Pacific and Other markets. Profiles of key leading companies engaged in the marketing and development of atrial fibrillation devices are covered, with additional information on the market position of major companies in the atrial fibrillation market.

Need a custom data table, graph, region, segment, companies or complete report? CUSTOMIZE NOW

Analyst Credentials

BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.

Latest reports include:
Let us assist you! Our analysts are ready to tailor this report to your specific need. REACH OUT TO US TODAY

Table of Contents

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter NamePagesMember Price
Full Report: Atrial Fibrillation: Technologies and Global Markets120Free
Chapter- 1: Introduction6Free
Chapter- 2: Summary and Highlights2Free
Chapter- 3: Background13Free
Chapter- 4: Market Overview11Free
Chapter- 5: Market Breakdown by Device Type38Free
Chapter- 6: Market Breakdown by Region10Free
Chapter- 7: Competitive Landscape and Recent Developments11Free
Chapter- 8: Company Profiles27Free
Chapter- 9: Appendix: Acronyms2Free

Related Reports

The Market for Minimally Invasive Medical Devices

Published - Aug 2023 | Publisher - Kottapenta Sai Ratna Bramara Kalyani | Code - HLC051J

The global minimally invasive medical devices market should reach $41.0 billion by 2028 from $28.5 billion in 2023 at a compound annual growth rate (CAGR) of 7.6% for the forecast period of 2023 to 2028.

Electroceuticals: Technologies and Global Markets

Published - Jul 2022 | Publisher - BCC Publishing | Code - MDS001B

The global electroceuticals market should reach $25.5 billion by the end of year 2022 and should reach more than $35.5 billion by year 2027, with a compound annual growth rate (CAGR) of 6.8% during the forecast period of 2022-2027.

Cardiovascular Drugs: Global Markets to 2022

Published - Apr 2018 | Publisher - BCC Publishing | Code - PHM191A

The global cardiovascular drugs market should reach $149.4 billion by 2022 from $141.1 billion in 2017 at a compound annual growth rate (CAGR) of 1.2%, from 2017 to 2022.

Cardiovascular Surgical Devices: Technologies and Global Markets

Published - Sep 2016 | Publisher - Bhavna Joshi | Code - HLC076C

The global market for cardiovascular surgical devices is expected to grow from nearly $37.0 billion in 2015 to $57.2 billion in 2020 at a compound annual growth rate of 9.4% from 2015-2020.

Recent Reports

Health and Medical Insurance Providers: Global Markets

Published - Jun 2024 | Publisher - BCC Publishing | Code - HLC212B

The global market for health and medical insurance providers is expected to grow from $2.2 trillion in 2023 to $3.4 trillion by the end of 2028, at a compound annual growth rate (CAGR) of 8.9% during the forecast period of 2023 to 2028.

Prefilled Syringes: Global Markets

Published - Jun 2024 | Publisher - BCC Publishing | Code - HLC223B

The global market for prefilled syringes is expected to grow from $14.5 billion in 2024 and is projected to reach $22.8 billion by the end of 2029, at a compound annual growth rate (CAGR) of 9.5% during the forecast period of 2024 to 2029.

Medical Robotics and Computer-assisted Surgery: The Global Market

Published - Jun 2024 | Publisher - BCC Publishing | Code - HLC036J

The global market for medical robotics and computer-assisted surgery is expected to grow from $11.5 billion in 2023 and projected to reach $19.5 billion by the end of 2028, at a compound annual growth rate (CAGR) of 11.0% during the forecast period of 2023 to 2028.

Medical Magnetic Resonance Imaging (MRI): Technologies and Global Markets

Published - May 2024 | Publisher - BCC Publishing | Code - HLC078F

The global market for medical magnetic resonance imaging (MRI) is expected to grow from $7.2 billion in 2023 and projected to reach $9.8 billion by the end of 2028, at a compound annual growth rate (CAGR) of 6.4% during the forecast period of 2023 to 2028.

Global Markets for Emerging Insulin Drug and Delivery Technologies: Focus on Syringes and Vials

Published - Mar 2024 | Publisher - Bejini Sandeep Kumar | Code - HLC156B

The global market for emerging insulin drug delivery devices is expected to grow from $55.8 billion in 2023 and projected to reach $88.9 billion by the end of 2028, at a compound annual growth rate (CAGR) of 9.8% from 2023 through 2028.

Top Trending Reports

Global Market for Cell and Gene Therapy

Published - Apr 2024 | Publisher - BCC Publishing | Code - BIO225B

The global market for cell and gene therapy is expected to grow from $7.2 billion in 2023 and projected to reach $23.3 billion by the end of 2028, at a compound annual growth rate (CAGR) of 26.4% during the forecast period of 2023 to 2028. 

Peptide Synthesis: Global Markets

Published - May 2024 | Publisher - BCC Publishing | Code - BIO252A

The global market for peptide synthesis is expected to grow from $90.1 billion in 2023 and projected to reach $157.5 billion by the end of 2028, at a compound annual growth rate (CAGR) of 11.8% during the forecast period of 2023 to 2028.

Medical Magnetic Resonance Imaging (MRI): Technologies and Global Markets

Published - May 2024 | Publisher - BCC Publishing | Code - HLC078F

The global market for medical magnetic resonance imaging (MRI) is expected to grow from $7.2 billion in 2023 and projected to reach $9.8 billion by the end of 2028, at a compound annual growth rate (CAGR) of 6.4% during the forecast period of 2023 to 2028.

3D Cell Cultures: Technologies and Global Markets

Published - Mar 2024 | Publisher - BCC Publishing | Code - BIO140D

The global market for 3D cell culture is estimated to increase from $4.6 billion in 2023 to reach $14.8 billion by 2028, at a compound annual growth rate (CAGR) of 26.5% from 2023 through 2028.

Oligonucleotides: Global Markets

Published - Apr 2024 | Publisher - BCC Publishing | Code - BIO220B

The global market for oligonucleotides is expected to grow from $7.0 billion in 2023 and projected to reach $11.7 billion by the end of 2028, at a compound annual growth rate (CAGR) of 11.0% during the forecast period of 2023 to 2028.

Become A Member

BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.

Find Out More

Custom Consulting

BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.

Customize Now

Scorecard

The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.

Find Out More

Innovation Spotlight

Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.

Find Out More
Atrial Fibrillation: Technologies and Global Markets
Customize Report